88
Views
2
CrossRef citations to date
0
Altmetric
Review

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

, , , , &
Pages 115-122 | Published online: 22 Oct 2010

References

  • ParkKTuberculosisPark’s Textbook of Preventive and Social Medicine17th edJabalpur, IndiaBanarsidas Bhanot Publishers2007175178
  • World Health OrganizationGlobal tuberculosis control 2008 – surveillance, planning, financing Available from: http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf. Accessed 2008 Jul 24.
  • DhedaKWarrenRMZumlaAGrobuschMPExtensively drug-resistant tuberculosis: Epidemiology and management challengesInfect Dis Clin North Am2010270572520674800
  • ChiangCYCentisRMiglioriGBDrug-resistant tuberculosis: Past, present, futureRespirology20101541343220337989
  • GandhiNRNunnPDhedaKMultidrug-resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosisLancet20103751830184320488523
  • CarvalhoACMiglioriGBCirilloDMTuberculosis in Europe: A problem of drug resistance or much more?Expert Rev Respir Med2010418920020406085
  • PrasadRRevised National Tuberculosis Control Programme: Current scenarioJ Indian Med Assoc200910772572720469748
  • MonederoICamineroJAMDR-/XDR-TB management: What it was, current standards and what is aheadExpert Rev Respir Med2009313314520477307
  • ShinSSKeshavjeeSGelmanovaIYDevelopment of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatmentAm J Respir Crit Care Med201018242643220413630
  • KödmönCHolloVHuitricEAmato-GauciAManisseroDMultidrug- and extensively drug-resistant tuberculosis: A persistent problem in the European Union and European economic areaEuro Surveill2010151951920338147
  • SharmaSKMohanAMultidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis controlChest200613026127216840411
  • AroraVKSinglaRDhingraVKWaresPrasad RSelvakumarSPanel discussion on MDR and XDR TBIndian J Tuberc20085510410918516829
  • O’BrienRJSpigelmanMNew drugs for tuberculosis: Current status and future prospectsClin Chest Med20052632734015837114
  • EspinalMALasersonKCamachoMDeterminants of drug-resistant tuberculosis: Analysis of 11 countriesInt J Tuberc Lung Dis2001588789311605880
  • SharmaSKMohanAScientific basis of directly observed treatment, short-course (DOTS)J Indian Med Assoc200310115715814603962
  • ManfrediRNanettiADal MontePCalzaLIncreasing pathomorphism of pulmonary tuberculosis: An observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?Braz J Infect Dis20091329730320231995
  • SharmaSKMohanAMultidrug-resistant tuberculosisIndian J Med Res200412035437615520486
  • KhatriGRFriedenTRControlling tuberculosis in IndiaN Engl J Med20023471420142512409545
  • SharmaSKLiuJJProgress of DOTS in global tuberculosis controlLancet200636795195216546549
  • BastianIRigoutsLvan DeunADirectly observed treatment, short-course strategy and multidrug-resistant tuberculosis: Are any modifications required?Bull World Health Organ20007823825110743297
  • BlumbergHMBurmanWJChaissonREAmerican Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America; treatment of tuberculosisAm J Respir Crit Care Med200316760366212588714
  • AlffenaarJWvan AltenaRHarmelinkIMComparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patientsClin Pharmacokinet2010455956520608757
  • AngerHADworkinFSharmaSMunsiffSSNilsenDMAhujaSDLinezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000–2006J Antimicrob Chemother20106577578320150181
  • AmaralLMartinsAMolnarJPhenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTBIn Vivo20102440942420668307
  • AmaralLBoereeMJGillespieSHUdwadiaZFvan SoolingenDThioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Int J Antimicrob Agents20103552452620188526
  • AmaralLMolnarJTherapy of XDR TB with thioridazine a drug beyond patent protection but eligible for patent “as new use”Recent Pat Antiinfect Drug Discov2010510911420156179
  • ZanettiSCannasSMolicottiPEvaluation of the antimicrobial properties of the essential oil of Lyrtus communis L. against clinical strains of Mycobacterium sppInterdiscip Perspect Infect Dis2010729 [Epub ahead of print]
  • GuptaRThakurBSinghPAnti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolatesIndian J Med Res201013180981320571171
  • OkadaMKitaYAnti-tuberculosis immunity by cytotoxic T cells* granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)Kekkaku201085531538 Japanese.20662249
  • Garcia-ContrerasLSungJCMuttilPDry powder PA-824 aerosols for treatment of tuberculosis in guinea pigsAntimicrob Agents Chemother2010541436144220086154
  • ManinaGPascaMRBuroniSde RossiERiccardiGDecaprenylph osphoryl-beta-D-ribose 2′-epimerase from Mycobacterium tuberculosis is a magic drug targetCurr Med Chem2010714 [Epub ahead of print]
  • RajniRMeenaLSGuanosine triphosphatases as novel therapeutic targets in tuberculosisInt J Infect Dis201014e682e68720207570
  • ChaitanyaMBabajanBAnuradhaCMExploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: A docking and molecular dynamics studyJ Mol Model2010161357136720140471
  • KhannaARajVSTaraiBEmergence of extensive drug resistant (XDR) Mycobacterium tuberculosis and molecular characterization of these clinical isolates from Delhi Region, IndiaAntimicrob Agents Chemother2010816 [Epub ahead of print]
  • BrossierFVezirisNAubryAJarlierVSougakoffWDetection by genotype MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolatesJ Clin Microbiol2010481683168920335420
  • EltringhamIJDrobniewskiFMultiple drug resistant tuberculosis: Aetiology, diagnosis and outcomeBr Med Bull19985456957810326285
  • TabarsiPChitsazEBaghaeiPImpact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: Report from IranMicrob Drug Resist201016818620192820
  • BrownPDrug resistant tuberculosis can be controlled, says WHOBMJ200032082110731157
  • KangMWKimHKChoiYSSurgical treatment for multidrug-resistant and extensive drug-resistant tuberculosisAnn Thorac Surg2010891597160220417785
  • EohHBrennanPJCrickDCThe Mycobacterium tuberculosis MEP (2C- methyl-d-erythritol 4-phosphate) pathway as a new drug targetTuberculosis (Edinb)20098911118793870